Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications-Reference-Cited by-同舟云学术

Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications

Published:2018-08-03 Issue:6 Volume:18 Page:655-666
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Leporowski Axel¹,Godman Brian²³⁴⁵^ORCID,Kurdi Amanj²⁶,MacBride-Stewart Sean⁷,Ryan Margaret⁷,Hurding Simon⁸,Do Nascimento Renata CRM²⁹¹⁰,Bennie Marion²,Morton Alec¹

Affiliation:

1. Department of Management Science, Strathclyde Business School, University of Strathclyde, Glasgow, United Kingdom

2. Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedicial Sciences, University of Strathclyde, Glasgow, United Kingdom

3. Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden

4. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

5. Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa

6. Department of pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq

7. Pharmacy Prescribing Support Unit, National Health Service Greater Glasgow and Clyde, Glasgow, UK

8. NHS Health Scotland, Edinburgh, UK

9. Post-Graduate Program of Medicines and Pharmaceutical Assistance, School of Pharmacy, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil

10. SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), School of Pharmacy, Federal University of Minas Gerais, Brazil

Funder

University of Strathclyde

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1501558

Reference77 articles.

1. Eurostat. Causes of death statistics 2017 updated 2017 Oct 11. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Causes_of_death_statistics. [Accessed 1 February 2018]

2. Forecasting the Future of Cardiovascular Disease in the United States

3. NCHStats. Statistics on statin use. Available from: https://nchstats.com/2013/11/14/statistics-on-statin-use/.

4. Despite Increased Use And Sales Of Statins In India, Per Capita Prescription Rates Remain Far Below High-Income Countries

5. Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Quality Indicators for Hypertension Management at the Primary Health Care Level in South Africa;2024-04-29

2. The long-term effect of generic price competition on the Hungarian statin market;BMC Health Services Research;2023-05-06

3. Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up;Frontiers in Pharmacology;2022-06-15

4. Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care;Frontiers in Pharmacology;2022-01-14

5. Sources of Information on Medicinal Products Among Physicians – A Survey Conducted Among Primary Care Physicians in Poland;Frontiers in Pharmacology;2022-01-06